Zobrazeno 1 - 10
of 440
pro vyhledávání: '"BRUNO GUERCI"'
Autor:
George Riley, Nicolas Scheyer, Marc Klein, Isabelle Merlot, Bruno Guerci, Elodie Jeanbert, Lea Demarquet
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
ObjectiveThe primary aim of this study was to identify predictive factors associated with onset of de-novo clinically significant pituitary insufficiencies following endoscopic endonasal surgery (EES) for pituitary adenomas. The secondary objective e
Externí odkaz:
https://doaj.org/article/58ce5be86b2b4d5f949a90a60d9771b0
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM). In this review
Externí odkaz:
https://doaj.org/article/6420101921534b9f9d011a67767b1819
Autor:
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, Petra-Maria Schumm-Draeger, Per Olav Vandvik, Tina Vilsbøll, Christoph Wanner, Carol Wysham, Eberhard Standl
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-16 (2022)
Abstract The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18–19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform fo
Externí odkaz:
https://doaj.org/article/00e116eff4ae44ebb18f8fbed0bc075e
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract The recent results of Cardiovascular Outcomes Trials (CVOTs) in type 2 diabetes have clearly established the cardiovascular (CV) safety or even the benefit of two therapeutic classes, Glucagon-Like Peptide-1 receptor agonists (GLP-1 RA) and
Externí odkaz:
https://doaj.org/article/c5cb3e8640224a6aa7275a1243794ca7
Autor:
Bruno Guerci, Yves Reznik, Pauline Schaepelynck, Emmanuel Sonnet, Salha Fendri, Marie-Françoise Jannot-Lamotte, Bogdan Nicolescu-Catargi, Valéria Cosma, Nathalie Texier, Justine Lahaye, Emmanuel Capitaine, Jean-Pierre Riveline
Publikováno v:
Médecine des Maladies Métaboliques. 17:281-290
Autor:
Charlotte Costentin, Cyrielle Caussy, Dominique Valla, Pierre Gourdy, Lawrence Serfaty, Jean-Michel Petit, Vincent Leroy, Aldo Trylesinski, Bruno Guerci
Publikováno v:
Médecine des Maladies Métaboliques. 17:271-280
Autor:
Camille Gosseaume, Thierry Fournier, Isabelle Jéru, Marie-Léone Vignaud, Isabelle Missotte, Françoise Archambeaud, Xavier Debussche, Céline Droumaguet, Bruno Fève, Sophie Grillot, Bruno Guerci, Sylvie Hieronimus, Yves Horsmans, Estelle Nobécourt, Catherine Pienkowski, Christine Poitou, Jean-Paul Thissen, Olivier Lascols, Séverine Degrelle, Vassilis Tsatsaris, Corinne Vigouroux, Camille Vatier
Publikováno v:
European Journal of Endocrinology. 188:273-281
ObjectiveThe adipogenic PPARG-encoded PPARγ nuclear receptor also displays essential placental functions. We evaluated the metabolic, reproductive, and perinatal features of patients with PPARG-related lipodystrophy.MethodsCurrent and retrospective
Publikováno v:
Médecine des Maladies Métaboliques. 16:543-549
Autor:
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis‐Emilio García‐Pérez
Publikováno v:
Diabetes, Obesity and Metabolism. 24:2373-2382
Autor:
Ashwaq Al-Jehani, Feras Al-Ahmed, Phi-Linh Nguyen-Thi, Florence Bihain, Claire Nomine-Criqui, Lea Demarquet, Bruno Guerci, Olivier Ziegler, Laurent Brunaud
Publikováno v:
Surgery. 172:552-558
Primary hyperparathyroidism is associated with an increased cardiovascular mortality, and its underlying mechanisms remain unclear. Insulin resistance has been suggested with low level of evidence. The goal of this study was to evaluate glucose metab